Antimicrobial prescription patterns in a tertiary-care pediatric unit in Thailand

Sineenart Chautrakarn1,2, Suvaporn Anugulruengkitt3,4, Thanyawee Puthanakit3,4

  • 1Department of Preventive and Social Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.

Insights

Nearly half of hospitalized children received antimicrobials. High meropenem use was noted, differing from other pediatric centers. This study offers baseline antimicrobial use data for Thailand.

Area of Science:

  • Pediatric pharmacology
  • Infectious disease epidemiology
  • Public health

Background:

  • Antimicrobial resistance is a global health crisis.
  • Inappropriate antibiotic prescribing fuels resistance.
  • Surveillance data is crucial for antimicrobial stewardship programs.

Purpose of the Study:

  • To determine antimicrobial use rates in a Thai pediatric unit.
  • To analyze antimicrobial prescription patterns.
  • To establish baseline data for stewardship initiatives.

Main Methods:

  • Monthly point prevalence survey from January to June 2016.
  • Included all pediatric inpatient beds.
  • Identified children receiving antimicrobial treatment.

Main Results:

  • 43.3% of 644 children received antimicrobials.
  • Prescription rates varied by ward (37.2% general to 67.7% surgical).
  • Meropenem and third-generation cephalosporins were frequently used.

Conclusions:

  • Antimicrobial use in hospitalized children is high, similar to international benchmarks.
  • Specific antimicrobial choices, like meropenem, warrant further investigation.
  • Findings provide essential data for future national antimicrobial surveillance.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
165
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
189
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
207
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
198
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
200
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
151